Connect
Newsfeed
A phase 3 clinical trial has unveiled a promising treatment for high-risk smoldering multiple myeloma, (SMM), a precancerous condition that can progress to active multiple myeloma,…
Mayo Clinic researchers have announced promising results from a groundbreaking study on glioblastoma – the most common and aggressive form of primary brain cancer. The…
Cancer fatigue or cancer-related fatigue, is a pervasive side effect of cancer and its treatments. This form of extreme exhaustion impacts not just energy levels but…
Uterine cancer is the most common gynecologic cancer in the U.S., with an estimated 67,880 new cases and 13,250 deaths expected in 2024, according to…
Clinical trials are the cornerstone of advancing cancer treatments, with nearly every therapy used today rooted in past trials. Despite their critical role, enrollment in…
From Alzheimer's disease and asthma to diabetes and a chemotherapy drug, researchers at Mayo Clinic are tapping the Sangre Por Salud (Spanish for "Blood for…
Connect